Skip to main content
OpenTrials
Completed

NCT Number: NCT03814512

Improving Insulin Resistance and Energy Metabolism Through Sleep Extension in Adolescents

The investigators propose to deliver a 4-week sleep extension intervention to adolescents to evaluate feasibility of the protocol and obtain preliminary data on intra-individual changes in metabolic parameters induced by sleep extension.

Completed

Looking for future studies?

Notify Me

Key information

Age range

13 year–19 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Children's Hospital Colorado

Lafayette, Colorado, 80026, United States

About this study

The specific aims of this feasibility study are to 1) examine the feasibility of recruitment and retention of adolescents with overweight/obesity, pre-diabetes, and inadequate sleep into a sleep extension intervention; 2) assess adherence of a sleep extension intervention to increase total sleep time in adolescents with overweight/obesity, pre-diabetes, and inadequate sleep; 3) determine estimates of mean and variability of potential intervention outcomes including metabolomic, body composition, and substrate oxidation. The investigators propose to deliver a 4-week sleep extension intervention to adolescents to evaluate feasibility of the protocol and obtain preliminary data on intra-individual changes in metabolic parameters induced by sleep extension.

This proposal is the first step to demonstrate feasibility in delivering the intervention in a research setting, measure the effect of the intervention on changing sleep duration, and examine changes in obesity-related IR metabolites that would lead to improved IR in an adolescent population with pre-diabetes. The long-term goal is to disseminate an effective and feasible T2D prevention program that can be sustainably implemented in clinical weight management settings.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • High school students between the age of 13-19 years
  • BMI >85th percentile for age and sex
  • Prediabetes defined as a HbA1c 5.7-6.4%
  • Tanner Stage 4-5 (based on breast development for girls and testicular size for boys)

Exclusion criteria

  • Any medications that affect insulin resistance or sleep (e.g., metformin, stimulants, atypical antipsychotics, current use of oral steroids)
  • Regular use of melatonin or other sleep aids
  • A prior diagnosis of a sleep disorder (e.g. insomnia, delayed sleep phase syndrome, obstructive sleep apnea) or abnormal scores on sleep disorders screening measures
  • Type 2 diabetes (HbA1c ≥ 6.5%)
  • IQ<70 or severe mental illness that may impact sleep or ability to consent/assent (e.g., schizophrenia, psychotic episodes), verified through chart review
  • Teens not enrolled in a traditional high school academic program (e.g., home school students)
  • Schedules that would preclude participants from adhering to the sleep extension protocol (e.g. night shift employment)
  • Travel across more than two time zones in the 2 weeks prior to the study

Treatment and study plan

Extended Sleep Intervention

Behavioral

Participants will receive an Extended Sleep Intervention (ES). Participants will be prescribed a sleep schedule that allows them to obtain approximately 1.5 h more time in bed compared to their typical sleep. Prescribed bedtimes and wake times will be determined collaboratively through discussion with participants and parents.

Primary outcomes

  1. Change in Total Sleep Time

    Time frame: up to 12 weeks

    The amount of time (hours:minutes) the participant sleeps post-intervention compared to pre-intervention

Sponsors and collaborators

Lead sponsor

University of Colorado, Denver

Other

Registry information

Official study title

Improving Insulin Resistance and Energy Metabolism Through Sleep Extension in Adolescents: The REM Study

Acronym: REM

Important dates

Study start
2019
Primary completion
2022
Study completion
2023
First posted
Jan 24, 2019
Registry last updated
Oct 1, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.